Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B, Patel M, Xu H, Guo HF, Zanzonico PB, Monette S, Yang G, Ouerfelli O, Nash GM, Cercek A, Fung EK, Howell RW, Larson SM, Cheal SM, Cheung NV. Chung SK, et al. Among authors: patel m. J Nucl Med. 2023 Sep;64(9):1439-1445. doi: 10.2967/jnumed.122.265095. Epub 2023 Jun 22. J Nucl Med. 2023. PMID: 37348919 Free PMC article.
Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses.
Cheal SM, McDevitt MR, Santich BH, Patel M, Yang G, Fung EK, Veach DR, Bell M, Ahad A, Vargas DB, Punzalan B, Pillarsetty NVK, Xu H, Guo HF, Monette S, Michel AO, Piersigilli A, Scheinberg DA, Ouerfelli O, Cheung NV, Larson SM. Cheal SM, et al. Among authors: patel m. Theranostics. 2020 Sep 14;10(25):11359-11375. doi: 10.7150/thno.48810. eCollection 2020. Theranostics. 2020. PMID: 33052220 Free PMC article.
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.
Chandler CS, Bell MM, Chung SK, Veach DR, Fung EK, Punzalan B, Burnes Vargas D, Patel M, Xu H, Guo HF, Santich BH, Zanzonico PB, Monette S, Nash GM, Cercek A, Jungbluth A, Pandit-Taskar N, Cheung NKV, Larson SM, Cheal SM. Chandler CS, et al. Among authors: patel m. Mol Cancer Ther. 2022 Jan;21(1):125-137. doi: 10.1158/1535-7163.MCT-21-0353. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667111 Free PMC article.
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
Cheal SM, Xu H, Guo HF, Patel M, Punzalan B, Fung EK, Lee SG, Bell M, Singh M, Jungbluth AA, Zanzonico PB, Piersigilli A, Larson SM, Cheung NV. Cheal SM, et al. Among authors: patel m. Theranostics. 2018 Oct 6;8(18):5106-5125. doi: 10.7150/thno.26585. eCollection 2018. Theranostics. 2018. PMID: 30429889 Free PMC article.
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.
Santich BH, Cheal SM, Ahmed M, McDevitt MR, Ouerfelli O, Yang G, Veach DR, Fung EK, Patel M, Burnes Vargas D, Malik AA, Guo HF, Zanzonico PB, Monette S, Michel AO, Rudin CM, Larson SM, Cheung NK. Santich BH, et al. Among authors: patel m. Clin Cancer Res. 2021 Jan 15;27(2):532-541. doi: 10.1158/1078-0432.CCR-20-2150. Epub 2020 Sep 21. Clin Cancer Res. 2021. PMID: 32958698 Free PMC article.
LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes.
Ding J, Nguyen AT, Lohman K, Hensley MT, Parker D, Hou L, Taylor J, Voora D, Sawyer JK, Boudyguina E, Bancks MP, Bertoni A, Pankow JS, Rotter JI, Goodarzi MO, Tracy RP, Murdoch DM, Rich SS, Psaty BM, Siscovick D, Newgard C, Herrington D, Hoeschele I, Shea S, Stein JH, Patel M, Post W, Jacobs D Jr, Parks JS, Liu Y. Ding J, et al. Among authors: patel m. J Clin Invest. 2024 May 15;134(10):e173278. doi: 10.1172/JCI173278. J Clin Invest. 2024. PMID: 38747290 Clinical Trial.
10,475 results
You have reached the last available page of results. Please see the User Guide for more information.